All news

Softly, softly...

Softly, softly...

German pharmaceutical company Boehringer Ingelheim has signed a
long-term agreement with software company MDL Information Systems
to use its software technology for managing and deploying chemical
information systems.

Flaming results

Flaming results

French drug delivery company Flamel Technologies reported a
significant leap in revenues for 2002 jumping from €12.3 million in
2001 to €19.8 million in 2002.

Fund setback for world leader

Fund setback for world leader

Applied Biosystems group, the world's number one maker of
gene-analysing equipment, warned on Tuesday that it would report
lower-than-expected fiscal third-quarter revenue and earnings due
to deteriorating business conditions.

The yolk of the matter

The yolk of the matter

The prospect of using chicken eggs as commercial 'biofactories' for
the production of protein-based drugs has moved a step closer with
the announcement of a study showing that transgenic cockerels can
pass on an introduced...

Asia-Pacfic focus

Asia-Pacfic focus

Singapore is the location for the first 'Drug Discovery Technology'
event organised by IBC Life Sciences in the Asia-Pacific region.

EU: Investment in R&D slipping

EU: Investment in R&D slipping

European scientists continue to be strong in areas such as medical
research and chemistry and Europe may produce the highest number of
science graduates but it is lagging behind in biotechnology, still
employs fewer researchers, accounts...

Life science boost

Life science boost

Strong sales from its life science unit helped US biotechnology
company Enzo Biochem, that specialises in gene identification
technologies, post total revenues of $13.1 million, compared with
$11.8 million in the corresponding year...

Spectrometer for proteomics

Spectrometer for proteomics

In the second mass spectrometer news of the week, life science
product company Agilent Technologies has introduced an ion trap
mass spectrometer that is approximately 10 times more sensitive
than its predecessor, the company claims.